2371P Avelumab first-line (1L) maintenance for advanced urothelial carcinoma (aUC): Long-term outcomes from the JAVELIN Bladder 100 trial in older patients (pts)
Gupta, S., Climent Duran, M.A., Sridhar, S., Powles, T.B., Bellmunt, J., Tyroller, K., Guenther, S., di Pietro, A., Grivas, P.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
2366P Phase I-II study of niraparib plus cabozantinib in patients with advanced urothelial/kidney cancer (NICARAGUA trial)
Castellano Gauna, D.E., Duran Martinez, I., Mellado Gonzalez, B., Climent Duran, M.A., Garcia Del Muro, X., Sala González, N., Alonso Gordoa, T., Sevillano Fernandez, E., Domenech Santasusana, M., Paramio, J., Real, F.X., Malats, N., Font Pous, A.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
1645P Tumour suppressor gene signature predicts early progression in metastatic hormone-sensitive metastatic prostate cancer (mHSPC) patients
Garcia De Herreros, M., Jimenez Blasco, N., Reig Torras, O., Ferrer Mileo, L., Aversa, C., García-Esteve, S., Rodríguez-Carunchio, L., Trias Puigsureda, I., Padrosa, J., Fernández Mañas, L., Marin, M., Font Pous, A., Rodriguez-Vida, A., Climent Duran, M.A., Cros Costa, S., Chirivella Gonzalez, I., Figols Gorina, M., Mellado Gonzalez, B.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
1601P First results from ZZFIRST: A randomized phase II trial of enzalutamide (EZ) with or without talazoparib (TALA) in metastatic hormone-naïve prostate cancer (mHNPC)
Mateo, J., Castro, E., Rodriguez-Vida, A., Gonzalez, B. Mellado, Gauna, D.E. Castellano, Climent Duran, M.A., Fernando, A. Borque, Sáez, M.I., Imbroda, B. Herrera, Pous, A. Font, Lorente, D., Morin, J. Planas, Vivancos, A., Cardona, J., Guerrero, J.A., Perez-Escuredo, J., Saavedra, A.J. Zurita, Galceran, J.C.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
1791P Molecular profiling and prognostic relevance of low PTEN expression in metastatic hormone-sensitive prostate cancer patients
Garcia De Herreros, M., Jimenez Blasco, N., Reig Torras, O., Ruiz de Porras, V., Pardo, J.C., Font Pous, A., Aversa, C., Ferrer-Mileo, L., Jorda, M., Rodríguez-Carunchio, L., Trias Puigsureda, I., Sánchez-Font, A., Rodriguez-Vida, A., Domenech Santasusana, M., Figols Gorina, M., Climent Duran, M.A., Chirivella Gonzalez, I., Herrero Rivera, D., Gonzalez Billalabeitia, E., Mellado Gonzalez, B.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
1793P PPROSTRATEGY: A SOGUG randomized trial of androgen deprivation therapy (ADT) plus docetaxel (dct) +/- nivolumab (nivo) or ipilimumab-nivolumab (ipi-nivo) in high-volume metastatic hormone-sensitive prostate cancer (hvHSPCa) - Safety and toxicity profiles from the pilot phase
Arranz Arija, J.A., Vazquez Estevez, S., Alonso Gordoa, T., Sepúlveda Sánchez, J.M., Perez Valderrama, B., Climent Duran, M.A., Gallardo Diaz, E., Lázaro Quintela, M., Lainez Milagro, N., Domenech Santasusana, M., Gonzalez del Alba Baamonde, M.A., Abad Villar, M.T., Crespo Herrero, G., Alvarez Fernandez, C., Mellado Gonzalez, B., Zambrana Tevar, F.J., Lopez Lopez, C., Perez Ramirez, S., Villa Guzmán, J.C., Piulats Rodriguez, J.M.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
1783P PROSTRATEGY: A SOGUG randomized trial of androgen deprivation therapy (ADT) plus docetaxel (dct) +/- nivolumab (nivo) or ipilimumab-nivolumab (ipi-nivo) in high-volume metastatic hormone-sensitive prostate cancer (hvHSPCa) - Efficacy results from the pilot phase
Arranz Arija, J.A., Piulats Rodriguez, J.M., Vazquez Estevez, S., Sepúlveda Sánchez, J.M., Alonso Gordoa, T., Perez Valderrama, B., Sala González, N., Climent Duran, M.A., Gallardo Diaz, E., Rodriguez-Vida, A., Caballero Diaz, C., Puente, J., Mendez Vidal, M.J., Parra, E.M.F., Martín, R.C., Virizuela Echaburu, J.A., Gragera, M.B.G., García Sanchez, J., García-Carbonero, I., Carles Galceran, J.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
1747P Impact of prior chemotherapy (Chemo) on pembrolizumab (Pembro) response in urothelial cancer (UC): Exploratory analysis of the phase III KEYNOTE-045 study
De Wit, R., Vaughn, D.J., Fradet, Y., Fong, L., Vogelzang, N.J., Climent Duran, M.A., Necchi, A., Petrylak, D.P., Gerritsen, W.R., Gurney, H.P., Quinn, D.I., Culine, S., Sternberg, C.N., Bajorin, D.F., Choueiri, T.K., Xu, J., Imai, K., Homet Moreno, B., Bellmunt, J., Lee, J-L.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
1448O Phase II KEYNOTE-B61 study of pembrolizumab (Pembro) + lenvatinib (Lenva) as first-line treatment for non-clear cell renal cell carcinoma (nccRCC)
Albiges, L., Gurney, H.P., Atduev, V., Suárez, C., Climent Duran, M.A., Pook, D., Tomczak, P., Barthelemy, P., Lee, J-L., Nalbandian, T., Stus, V., Ferguson, T., Wiechno, P., Gokmen, E., Lacombe, L., Gedye, C., Perini, R., Sharma, M., C. Li, Lee, C-H.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
745P Patient-reported outcomes (PROs) from JAVELIN Bladder 100: Avelumab first-line (1L) maintenance + best supportive care (BSC) vs BSC alone for advanced urothelial carcinoma (UC)
Powles, T.B., Kopyltsov, E., Su, P-J., Parnis, F.X., Park, S.H., Yamamoto, Y., Fong, P.C., Tournigand, C., Climent Duran, M.A., Bamias, A., Caserta, C., Chang, J., Yan, E., di Pietro, A., Wang, J., Grivas, P.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
803TiP Pilot study of cabozantinib efficacy, safety and tolerability in metastatic renal carcinoma in aged fragile patients
Climent Duran, M.A., Basterretxea, L., Sanchez Escribano, R., Llabres, E., Heras Lopez, L., Zambrana, F., Torregrosa, M.D., Girones Sarrio, R., Villa Guzman, J.C., Juan Fita, M.J., Fernandez Nuñez, N.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
625P TMPRSS2-ERG expression and clinical evolution of metastatic hormone sensitive prostate cancer
Aversa, C., Jimenez, N., Marín-Aguilera, M., Ferrer, L., Rodríguez-Carunchio, L., Diaz-Mercedes, S., Font Pous, A., Rodriguez-Vida, A., Domenech Santasusana, M., Figols Gorina, M., Climent Duran, M.A., Cros Costa, S., Chirivella, I., Herrero Rivera, D., Gonzalez-Billalabeitia, E., Jiménez-Peralta, D., Carles Galceran, J., Suarez Rodriguez, C., Reig Torras, O., Mellado, B.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
589P Dynamics of peripheral blood immune profiling associated with tumour progression in metastatic castration resistant prostate cancer (mCRPC)
Perez Navarro, E., Conteduca, V., Gonzalez del Alba, A., Mellado, B., Cremaschi, P., Fernandez Calvo, O., Mendez Vidal, M.J., Climent Duran, M.A., Duran, I., Gallardo Diaz, E., Vazquez, S., Font Pous, A., Gurioli, G., Martínez, A., López Andreo, M.J., Attard, G., Castellano Gauna, D., Grande, E., Giorgi, U., Gonzalez Billalabeitia, E.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
666P Pembrolizumab (pembro) monotherapy as first-line therapy in advanced clear cell renal cell carcinoma (ccRCC): Results after a minimum of 41 months of follow-up from KEYNOTE-427 cohort A
McDermott, D.F., Lee, J-L., Bjarnason, G.A., Larkin, J., Gafanov, R., Kochenderfer, M.D., Jensen, N.V., Donskov, F., Malik, J., Poprach, A., Tykodi, S.S., Alonso-Gordoa, T., Cho, D.C., Geertsen, P.F., Climent Duran, M.A., Di Simone, C., Liu, H., Burgents, J., Rodriguez-Lopez, K., Atkins, M.B.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
1572P The impact of COVID-19 pandemic on Spanish genitourinary (GU) cancer patients: SOGUG-COVID-19 study
Duran, M.A. Climent, Vidal, N., Pérez, S., Méndez-Vidal, M.J., Anguera, G., Salas, I. Martinez, Gallardo, E., Cuellar, M.A., Soto, J.J., Martín, A., Domènech, M., Rodriguez-Vida, A., Casado, E. Almagro, Diaz-Mejía, N., Kareaga, M. Martinez, Calvo, O. Fernandez, Guzmán, J.C. Villa, Vazquez, S., Gonzalez del Alba, A., Puente, J.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
LBA27 Phase II multicenter, randomized study to evaluate efficacy and safety of avelumab with gemcitabine/carboplatin (CG) vs CG alone in patients with unresectable or metastatic urothelial carcinoma (mUC) who are ineligible to receive cisplatin-based therapy
Perez Valderrama, B., Castellano Gauna, D., Pinto Marin, A., Mellado Gonzalez, B., Puente, J., Climent Duran, M.A., Domènech, M., Vazquez Mazon, F.J., Perez Gracia, J.L., Bonfill, T., Morales Barrera, R., Ballester Navarro, I., Garcia del Muro, X., Maroto, P., Juan Vidal, O.J., Rodriguez-Vida, A., Bellmunt, J.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
759P Towards personalized medicine in MIBC: Immunohistochemistry-based taxonomical classification and outcome in patients treated with adjuvant chemotherapy
Gauna, D. Castellano, Grande, E., Duran, M.A. Climent, Lainez, N., Duran, I., Carrato, C., Lobato, T., Andrada, E., Gonzalez, R. Gonzalez, Astudillo, L., Estevez, S. Vazquez, Gonzalez, B. Mellado, Carbonero, I. García, Quintela, M. Lázaro, Saez, M., Billalabeitia, E. Gonzalez, Arnau, M. Guix, Font, A., Malats, N., Real, F.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
752P Updated data from the NORSE trial of erdafitinib (ERDA) plus cetrelimab (CET) in patients (pts) with metastatic or locally advanced urothelial carcinoma (mUC) and specific fibroblast growth factor receptor (FGFR) alterations
Siefker-Radtke, A.O., Loriot, Y., Siena, S., Beato, C., Duran, M.A. Climent, Varlamov, S., Duran, I., Tagawa, S.T., Geoffrois, L., Mellado, B., Semenov, A., Delva, R., Lykov, A.P., Dirix, L.Y., Akapame, S., O'Hagan, A., Tammaro, M., Mosher, S., Kang, T.W., Moreno, V.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
Longer time from diagnosis to docetaxel treatment results in a shorter survival in metastatic hormonosensitive prostate cancer (mHSPC) patients treated with chemotherapy+androgen deprivation therapy (ADT)
Climent Duran, M.A., Mellado, B., Piulats Rodriguez, J.M., Heras Lopez, L., Juan, M.J., Sáez, M.I., Reig, O., Montesa, A., Suarez, J.F., Hajianfar, R., Ribal, M.J., Rubio, J., Castells, M., Villatoro, R., Sandiego, S., Olmos Hidalgo, D.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article
SPAZO2 (SOGUG): Comparative effectiveness of pazopanib in metastatic renal carcinoma (mRC): Ineligible (I) vs eligible (E) patients for clinical trials
Arranz Arija, J., Pérez Valderrama, B., Rodríguez Sánchez, Á., Chirivella González, I., Anido Herranz, U., Maroto Rey, J.P., Miranda Pallares, M.J., Climent Duran, M.A., Crespo Herrero, G., Meana Garcia, J.A., Rodriguez-Vida, A., Fernandez-Rodriguez, R., Santander, C., Rubio Romero, G., Vazquez Estevez, S., Fernandez Calvo, O., Gonzalez Gragera, M.B., Almagro Casado, E., Perez Ramirez, S., Borrega García, P.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article